Dissolving filler: when it's the right call

Why hyaluronidase exists

Hyaluronic acid is the molecule that holds moisture and volume in skin and connective tissue. It's the same substance your body makes naturally. All HA fillers are built on this chemistry, which makes them reversible in a way that permanent fillers are not.

Hyaluronidase is an enzyme that degrades hyaluronic acid, modulating tissue permeability and breaking down the filler matrix. When injected into tissue containing HA filler, hyaluronidase activity is rapid. Pharmacokinetic analysis shows the enzyme's activity diminishes within 30 minutes in biological tissues, though it retains functionality for approximately 6 hours post-injection. This narrow window is why timing matters for emergency use and why staged dissolution over multiple appointments works for elective cases.

When dissolution is a medical emergency

Vascular occlusion is the most serious filler complication. It occurs when filler inadvertently enters or compresses a blood vessel, cutting off blood supply to the skin or deeper structures. Without immediate treatment, this can lead to skin necrosis, blindness, or stroke.

If you experience blanching (sudden whiteness), dusky discolouration, pain disproportionate to the injection, or visual symptoms after filler, this is a medical emergency. The clinic should immediately inject high-dose hyaluronidase (200-300 units as a first bolus) widely around the ischemic area to reverse the occlusion. If discolouration persists after 10 minutes, a further 200-300 units should be reinjected after 60 minutes.

The stakes here are absolute: if vascular occlusion is treated with ultrasound guidance and high-dose hyaluronidase within four to six hours, ischemia can be reversed in up to 80 per cent of cutaneous cases. Delay or denial of treatment dramatically worsens outcomes. This is why every clinic injecting fillers must carry hyaluronidase stock and understand emergency protocols.

When dissolution is elective

Most dissolution requests are elective. The filler itself isn't causing harm, but the result isn't what the client wants. Common reasons include:

• · Over-treatment (too much volume injected).
• · Migration (filler has moved to an unintended location).
• · Lumping or beading (the filler has clumped rather than integrated smoothly).
• · Tyndall effect (blue or grey discolouration under thin skin, typical on lower lids).
• · Dissatisfaction with the result (asymmetry, shape, or simply a wish to reset and start fresh).
• · Swelling or inflammation from a hypersensitivity reaction.
• · Suspected or confirmed infection.

For elective dissolution, the approach is conservative. Rather than removing all filler immediately, most clinicians use staged dosing. A test patch (a small injection of hyaluronidase in a limited area) is injected first to assess the client's reaction. The remaining filler is then treated with lower doses, and reassessment occurs after 24-48 hours before any further doses are given. This prevents over-dissolution and allows you to see the true baseline underneath.

Dosing: the difference between emergency and elective

The dose of hyaluronidase depends on the urgency and the amount of filler present.

For elective reversals, approximately 5 units of hyaluronidase are required to dissolve 0.1 mL of standard 20 mg/mL HA filler. However, modern fillers with stronger cross-linking require higher doses. Softer fillers used for wrinkles typically need 200-300 units per 1 mL, whilst volumising fillers may require over 500 units per 1 mL. Biphasic fillers respond more quickly than monophasic ones, so your clinician must know the exact filler product and batch to dose accurately.

For vascular occlusion, dosing is dramatically higher. Up to 1500-3000 units may be injected widely around the ischemic area to ensure adequate vascular infiltration and rapid reversal. This is not a measured aesthetic dose; it is a medical rescue dose.

Why reversal must happen in clinic with stock on hand

Hyaluronidase carries real risks. Allergic reactions are possible (though rare). The enzyme can cause tissue damage if injected into unintended structures. And if something goes wrong, you need immediate medical support, not a trip to A&E or a call to another clinic.

This is why dissolution should only be performed by trained practitioners in a clinic environment where hyaluronidase is held in stock. If you're considering dissolving filler injected elsewhere, ask the prospective clinic whether they keep hyaluronidase on hand and whether the practitioner is qualified to manage complications. If the answer is no, walk away.

In my clinic, we hold hyaluronidase stock and have emergency protocols in place. Every filler client is informed that reversal is available should they need it, and every practitioner is trained in recognition and management of vascular complications. This isn't optional insurance; it's the baseline standard of safe practice.

The test patch and staged approach

Before dissolving a full area, a test patch is injected into a small, inconspicuous part of the treatment zone. This serves two purposes: it confirms that your body tolerates the enzyme, and it shows how much filler reduction occurs with a modest dose. Some clients dissolve easily; others need repeated treatments.

After 24-48 hours, you're reviewed. If all is well and you still want further dissolution, a second round of hyaluronidase is injected. This staged approach reduces the risk of over-treatment and gives you a chance to see what your face looks like as filler is progressively removed. It also allows your practitioner to see exactly which areas need further work.

Visible reduction typically occurs within 24-72 hours of injection. But don't judge the result too early. Swelling from the hyaluronidase itself can make the area look temporarily fuller or more inflamed. Wait at least a week before making further decisions.

What happens to your natural tissue afterwards

Once the filler is dissolved, you return to your baseline. The hyaluronidase breaks down the HA filler, and your body clears the debris. Your natural tissue is not altered. The skin, muscle, and bone underneath remain unchanged because the filler never integrated into your tissues; it sat in the space between them, held in place by the filler matrix.

If over-treatment was the problem, you'll look slimmer or more defined once the excess is gone. If migration was the issue, you'll see the contour normalise. If you simply want a reset, you have a clean slate to start afresh, either with no treatment or with a more conservative approach next time.

Swelling from the hyaluronidase injection itself usually settles within 2-3 days. Bruising is possible but uncommon. Once resolved, the only change is the absence of filler.

A short safety note

Hyaluronidase is a prescription-only medicine in the UK and should only be prescribed and injected by a qualified healthcare professional. The June 2025 update to NMC guidance requires nurse and midwife prescribers to conduct a face-to-face consultation before prescribing aesthetic emergency medicines, including hyaluronidase. This is sensible regulation. It means your practitioner must assess you in person and have a documented reason for dissolving your filler.

If you're seeking dissolution from a non-clinical setting or a practitioner who cannot immediately manage a complication, you're putting yourself at risk. A clinic with no hyaluronidase stock, no emergency protocols, and no medical oversight is not safe. Your safety is non-negotiable.